These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 1707469)
1. Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines. Jernberg H; Pettersson M; Kishimoto T; Nilsson K Leukemia; 1991 Mar; 5(3):255-65. PubMed ID: 1707469 [TBL] [Abstract][Full Text] [Related]
2. Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop. Jernberg-Wiklund H; Pettersson M; Carlsson M; Nilsson K Leukemia; 1992 Apr; 6(4):310-8. PubMed ID: 1588793 [TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6. Westendorf JJ; Ahmann GJ; Greipp PR; Witzig TE; Lust JA; Jelinek DF Leukemia; 1996 May; 10(5):866-76. PubMed ID: 8656685 [TBL] [Abstract][Full Text] [Related]
4. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA. Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457 [TBL] [Abstract][Full Text] [Related]
5. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines. Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222 [TBL] [Abstract][Full Text] [Related]
6. A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth. Jelinek DF; Witzig TE; Arendt BK J Immunol; 1997 Jul; 159(1):487-96. PubMed ID: 9200490 [TBL] [Abstract][Full Text] [Related]
7. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells. Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193 [TBL] [Abstract][Full Text] [Related]
8. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines. Morinaga Y; Suzuki H; Takatsuki F; Akiyama Y; Taniyama T; Matsushima K; Onozaki K J Immunol; 1989 Dec; 143(11):3538-42. PubMed ID: 2584706 [TBL] [Abstract][Full Text] [Related]
9. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1. Jourdan M; De Vos J; Mechti N; Klein B Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262 [TBL] [Abstract][Full Text] [Related]
10. IL-4 and TNF-alpha-mediated proliferation of the human megakaryocytic line M-O7E is regulated by induced autocrine production of GM-CSF. Wadhwa M; Dilger P; Meager A; Walker B; Gaines-Das R; Thorpe R Cytokine; 1996 Dec; 8(12):900-9. PubMed ID: 9050748 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Okamoto M; Lee C; Oyasu R Cancer Res; 1997 Jan; 57(1):141-6. PubMed ID: 8988055 [TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor is a survival and proliferation factor for human myeloma cells. Jourdan M; Tarte K; Legouffe E; Brochier J; Rossi JF; Klein B Eur Cytokine Netw; 1999 Mar; 10(1):65-70. PubMed ID: 10210775 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line. Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862 [TBL] [Abstract][Full Text] [Related]
14. Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism. Goto H; Shimazaki C; Tatsumi T; Yamagata N; Fujita N; Tsuchiya M; Koishihara Y; Ohsugi Y; Nakagawa M Leukemia; 1995 Apr; 9(4):711-8. PubMed ID: 7723407 [TBL] [Abstract][Full Text] [Related]
15. Four cell-secreted cytokines act synergistically to maintain long term proliferation of human B cell lines in vitro. Abken H; Fluck J; Willecke K J Immunol; 1992 Oct; 149(8):2785-94. PubMed ID: 1328386 [TBL] [Abstract][Full Text] [Related]
16. IFN-alpha induces autocrine production of IL-6 in myeloma cell lines. Jourdan M; Zhang XG; Portier M; Boiron JM; Bataille R; Klein B J Immunol; 1991 Dec; 147(12):4402-7. PubMed ID: 1753108 [TBL] [Abstract][Full Text] [Related]
17. Recombinant human granulocyte-macrophage colony-stimulating factor induces secretion of autoinhibitory monokines by U-937 cells. Lindemann A; Riedel D; Oster W; Mertelsmann R; Herrmann F Eur J Immunol; 1988 Mar; 18(3):369-74. PubMed ID: 3281850 [TBL] [Abstract][Full Text] [Related]
18. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression. Westendorf JJ; Jelinek DF J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241 [TBL] [Abstract][Full Text] [Related]
20. Expression and production of interleukin 10 in human myeloma cell lines. Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]